MIGS improves quality of life, clinical parameters
Minimally invasive glaucoma procedures are emerging as a safe and effective way to manage glaucoma. However, there has been limited evidence regarding the impact of these procedures on patients’ quality of life.
A new study explored the impact of minimally invasive glaucoma surgery (MIGS) combined with phacoemulsification and found it was associated with improved quality of life and clinical parameters related to the ocular surface in patients previously treated with anti-glaucoma therapy.
The retrospective observational study included 57 consecutive patients who underwent iStent combined with phacoemulsification with or without adjunctive endocyclophotocoagulation and were followed for 4 months.
Patients reported statistically significant improvements in their glaucoma-specific and general health scores. Patients also experienced significant improvements in ocular surface PROMs, tear film break-up time, and corneal fluorescein staining.
In addition, patients required fewer eye drops on average after MIGS compared to before surgery.
Reference
Jones L, Maes N, Qidwai U, et al. Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma. Ther Adv Ophthalmol. 2023;15:25158414231152765. doi: 10.1177/25158414231152765. PMID: 37077654; PMCID: PMC10107052.
